Provided by Tiger Trade Technology Pte. Ltd.

Cabaletta Bio

2.91
-0.3600-11.01%
Pre-market: 2.970.0600+2.06%04:58 EDT
Volume:6.51M
Turnover:19.91M
Market Cap:494.70M
PE:-1.89
High:3.28
Open:3.28
Low:2.90
Close:3.27
52wk High:4.23
52wk Low:1.72
Shares:170.00M
Float Shares:141.48M
Volume Ratio:1.08
T/O Rate:4.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5420
EPS(LYR):-2.1000
ROE:-93.20%
ROA:-48.19%
PB:2.35
PE(LYR):-1.39

Loading ...

Cabaletta Bio presents new data for rese-cel in autoimmune diseases

TIPRANKS
·
Jun 03

Cabaletta Bio Highlights Rese-cel Data and Pivotal Path

TIPRANKS
·
Jun 03

Cabaletta Bio's Rese-cel Shows Potential in Treating Autoimmune Diseases

MT Newswires Live
·
Jun 03

Cabaletta Bio posts corporate presentation on rese-cel CD19 CAR-T autoimmune disease programs

Reuters
·
Jun 03

Cabaletta Bio Announces New Rese-cel Data and Development Updates Across Autoimmune Portfolio, Including Encouraging Early PC-Free Lupus Findings, at EULAR 2026 Congress

GlobeNewswire
·
Jun 03

Cabaletta Bio Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
May 15

Wells Fargo Gives a Hold Rating to Cabaletta Bio (CABA)

TIPRANKS
·
May 15

Analyst Reiterates Buy on Cabaletta Bio Citing Strong Cash Runway and Promising Early Rese-cel Data in Autoimmune Diseases

TIPRANKS
·
May 15

Analyst Reiterates Buy on Cabaletta Bio, Citing Strong Non-Preconditioned PV Data, Scalable Manufacturing, and Multiple Upcoming Catalysts

TIPRANKS
·
May 15

Cabaletta Bio Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 14

Cabaletta Bio presents new clinical data for rese-cel

TIPRANKS
·
May 14

Cabaletta Bio Reports Encouraging RESET-PV Trial Data

TIPRANKS
·
May 14

Cabaletta Bio Q1 EPS $(0.39), Inline

Benzinga Earnings
·
May 14

Cabaletta Bio Q1 net loss widens as R&D costs rise

Reuters
·
May 14

Cabaletta Bio Q1 EPS USD -0.39

THOMSON REUTERS
·
May 14

Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 14

Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting

GlobeNewswire
·
May 14

U.S. Earnings Preview: Before Market Open May 13

Dow Jones
·
May 13

Top News Today: Stocks Mixed, Oil Rises After Hot Inflation Data

Dow Jones
·
May 13

Cabaletta Bio Inc expected to post a loss of 40 cents a share - Earnings Preview

Reuters
·
May 11